Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3223-3227

  Nagamori, Masashi ^a,b   Kawaguchi, Satoshi ^a   Murakami, Masaaki ^b   Wada, Takuro ^a   Nagoya, Satoshi ^a   Yamashita, Toshihiko ^a   Inobe, Manabu ^b   Uede, Toshimitsu ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anti tumor immunity; B7 1; Costimulatory molecule; CTLA 4; Osteosarcoma

Indexed keywords

B7 1ALPHA ANTIGEN; B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; TUMOR VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENETIC ENGINEERING; GENETIC TRANSFECTION; LUNG METASTASIS; MALE; MOLECULAR INTERACTION; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; BONE NEOPLASMS; CANCER VACCINES; IMMUNOCONJUGATES; IMMUNOTHERAPY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C3H; OSTEOSARCOMA; TRANSFECTION;

EID: 0036870087     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hurwitz AA, Kwon ED and Elsas A: Costimulatory wars: the tumor menace. Curr Opin Immunol 12: 589-596, 2000.
2. Abbas AK and Sharpe AH: T-cell stimulation: an abundance of B7s. Nat Med 5: 1345-1346, 1999.
3. Coyle AJ and Gutierrez-Ramos J-C: The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2: 203-209, 2001.
4. Inobe M, Linsley PS, Ledbetter JA, Nagai Y, Tamakoshi M and Uede T: Identification of an alternatively spliced form of the murine homologue of B7. Biochem Biophys Res Commun 200: 443-449, 1994.
5. Chambers CA and Allison JP: Costimulatory regulation of T cell function. Curr Opin Cell Biol 11: 203-210, 1999.
6. Nagamori M, Kawaguchi S, Murakami M, Wada T, Inobe M, Ishii S and Uede T: In vivo immunogenecity of osteosarcoma cells that express B7-1a, an alternatively spliced form of B7-1. Anticancer Res 22: (in press), 2002.
7. Walunas TL, Lenschow DL, Bakker C, Y, Linsley PS, Freeman GJ, Thompson CB and Blustone JA: CTLA-4 can function as a negative regulator of T cell activation. Immunity 1: 405-413, 1994.
8. Ueda T, Aoki Y, Yoshikawa H, Kato T, Hamada H and Ono K: Establishment of highly pulmonary metastatic cell line of murine osteosarcoma. Jap J Orthop Res 13: 705-708, 1986.
9. Wu T-C, Huang AYC, Jaffee EM, Levitsky HI and Pardoll DM: A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med 182: 1415-1421, 1995.
10. Leach DR, Krummel MF and Allison JP: Enhancement of anti-tumor immunity by CTLA-4 blockage. Science 271: 1734-1736, 1996.
11. Sotomayor EM, Borrello I, Tubb E, Allison JP and Levitsky HI: In vivo blockage of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc Natl Acad Sci USA 96: 11476-11481, 1999.
12. Yang Y-F, Zou J-P, Wijesuriya R, Ono S, Walunas T, Bluestone J, Fujiwara H and Hamaoka T: Enhanced induction of anti-tumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages. Cancer Res 57: 4036-4041, 1997.
13. Mokyr MB, Kalinichenko T, Gorelik L and Bluestone JA: Realization of the therapeutic potential of CTLA-4 blockage in low-dose chemotherapy-treated tumor-bearing mice. Cancer Res 58: 5301-5304, 1998.
14. Hurwitz AA, Yu TF-Y, Leach DR and Allison JP: CTLA-4 blockade synergizes with tumor-drived granulocyte-macrophage colony- stimulating factor for treatment of an experimental mammary carcinoma. Proc Natl Acad Sci USA 95: 10067-10071, 1998.
15. van Elsas A, Hurwitz AA and Allison JP: Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte- associated antigen 4 (CTLA-4) and granulocyte/macrophage colony- stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 190: 355-366, 1999.
16. Van Ginderachter JA, Liu Y, Geldhof AB, Brijs L, Thielemans K, De Baetselier P and Raes G: B7-1, IFN gamma and anti-CTLA-4 cooperate to prevent T-cell tolerization during immunotherapy against a murine T lymphoma. Int J Cancer 87: 539-547, 2000.
17. Hernandez J, Ko A and Sherman LA: CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen. J Immunol 166: 3908-3914, 2001.
18. Ito D, Ogasawara K, Iwabuchi K, Inuyama Y and Onoe K: Induction of CTL responses by simultaneous administration of lippsomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb. J Immunol 164: 1230-1235, 2000.
19. Ogihara Y, Takeda K, Yanagawa T and Hirawasa Y: Spontaneous regression of lung metastases from osteosarcoma. Cancer 74: 2798-2803, 1994.
20. Sabate JM, Llauger J, Torrubia S, Amores S and Franquet T: Osteosarcoma of the abdominal wall with spontaneous regression of lung metastases. Am J Roentgenol 171: 691-692, 1998.
21. Hayakawa M, Kawaguchi S, Ishii S, Murakami M and Uede T: B7-1-transfected tumor vaccine counteracts chemotherapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells. Int J Cancer 71: 1091-1102, 1997.